Different Serotonergic Expression in Nevomelanocytic Tumors

The neuromediator serotonin (5-hydroxytryptamine; 5-HT) has been proposed to play a role in tumor progression. Thus, the aim of the present investigation was to determine whether alterations in the serotonergic system occur in nevomelanocytic tumors. For this purpose, paraffin-embedded biopsies of s...

Full description

Bibliographic Details
Main Authors: Clara Naimi-Akbar, Markus Ritter, Sasika Demel, Husameldin El-Nour, Mari-Anne Hedblad, Efrain C. Azmitia, Klas Nordlind
Format: Article
Language:English
Published: MDPI AG 2010-06-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/2/2/1166/
id doaj-30bd84cbfea04ad5a7344a60a180de58
record_format Article
spelling doaj-30bd84cbfea04ad5a7344a60a180de582020-11-24T22:02:00ZengMDPI AGCancers2072-66942010-06-01221166117710.3390/cancers2021166Different Serotonergic Expression in Nevomelanocytic TumorsClara Naimi-AkbarMarkus RitterSasika DemelHusameldin El-NourMari-Anne HedbladEfrain C. AzmitiaKlas NordlindThe neuromediator serotonin (5-hydroxytryptamine; 5-HT) has been proposed to play a role in tumor progression. Thus, the aim of the present investigation was to determine whether alterations in the serotonergic system occur in nevomelanocytic tumors. For this purpose, paraffin-embedded biopsies of superficial spreading malignant melanoma (SSM), dysplastic compound nevi (DN) and benign compound nevi (BCN) were characterized with regard to their expression of 5-HT, the 5-HT1A and 5-HT2A receptors, and the serotonin transporter protein (SERT), by immunohistochemical analysis. Melanocytes in the region surrounding the tumor were found to express both the 5-HT1A and 5-HT2A receptors. Tumor cells that immunostained positively for the different serotonergic markers were observed in the suprabasal epidermis of DN tissue and, to an even greater extent, in the case of SSM. Furthermore, some of these latter cells expressed both 5-HT1AR and 5-HT2AR. The level of expression of 5-HT1AR at the junctional area was lower for SSM than for DN or BCN. As the degree of atypia increased, the intensity of tumor cell staining in the dermis for 5-HT1AR and SERT declined. Vessel immunoreactivity for 5-HT2A was more intense in SSM than in BCN tissue. Round-to-dendritic cells that expressed both SERT and 5-HT1AR were seen to infiltrate into the dermal region of the tumor, this infiltration being more evident in the case of DN and SSM. These latter cells were also tryptase-positive, indicating that they are mast cells. Thus, alterations in serotonergic system may be involved in nevomelanocytic tumors and mast cells may play an important role in this connection. http://www.mdpi.com/2072-6694/2/2/1166/melanomaserotoninreceptorserotonin transporter proteinimmunohistochemistry
collection DOAJ
language English
format Article
sources DOAJ
author Clara Naimi-Akbar
Markus Ritter
Sasika Demel
Husameldin El-Nour
Mari-Anne Hedblad
Efrain C. Azmitia
Klas Nordlind
spellingShingle Clara Naimi-Akbar
Markus Ritter
Sasika Demel
Husameldin El-Nour
Mari-Anne Hedblad
Efrain C. Azmitia
Klas Nordlind
Different Serotonergic Expression in Nevomelanocytic Tumors
Cancers
melanoma
serotonin
receptor
serotonin transporter protein
immunohistochemistry
author_facet Clara Naimi-Akbar
Markus Ritter
Sasika Demel
Husameldin El-Nour
Mari-Anne Hedblad
Efrain C. Azmitia
Klas Nordlind
author_sort Clara Naimi-Akbar
title Different Serotonergic Expression in Nevomelanocytic Tumors
title_short Different Serotonergic Expression in Nevomelanocytic Tumors
title_full Different Serotonergic Expression in Nevomelanocytic Tumors
title_fullStr Different Serotonergic Expression in Nevomelanocytic Tumors
title_full_unstemmed Different Serotonergic Expression in Nevomelanocytic Tumors
title_sort different serotonergic expression in nevomelanocytic tumors
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2010-06-01
description The neuromediator serotonin (5-hydroxytryptamine; 5-HT) has been proposed to play a role in tumor progression. Thus, the aim of the present investigation was to determine whether alterations in the serotonergic system occur in nevomelanocytic tumors. For this purpose, paraffin-embedded biopsies of superficial spreading malignant melanoma (SSM), dysplastic compound nevi (DN) and benign compound nevi (BCN) were characterized with regard to their expression of 5-HT, the 5-HT1A and 5-HT2A receptors, and the serotonin transporter protein (SERT), by immunohistochemical analysis. Melanocytes in the region surrounding the tumor were found to express both the 5-HT1A and 5-HT2A receptors. Tumor cells that immunostained positively for the different serotonergic markers were observed in the suprabasal epidermis of DN tissue and, to an even greater extent, in the case of SSM. Furthermore, some of these latter cells expressed both 5-HT1AR and 5-HT2AR. The level of expression of 5-HT1AR at the junctional area was lower for SSM than for DN or BCN. As the degree of atypia increased, the intensity of tumor cell staining in the dermis for 5-HT1AR and SERT declined. Vessel immunoreactivity for 5-HT2A was more intense in SSM than in BCN tissue. Round-to-dendritic cells that expressed both SERT and 5-HT1AR were seen to infiltrate into the dermal region of the tumor, this infiltration being more evident in the case of DN and SSM. These latter cells were also tryptase-positive, indicating that they are mast cells. Thus, alterations in serotonergic system may be involved in nevomelanocytic tumors and mast cells may play an important role in this connection.
topic melanoma
serotonin
receptor
serotonin transporter protein
immunohistochemistry
url http://www.mdpi.com/2072-6694/2/2/1166/
work_keys_str_mv AT claranaimiakbar differentserotonergicexpressioninnevomelanocytictumors
AT markusritter differentserotonergicexpressioninnevomelanocytictumors
AT sasikademel differentserotonergicexpressioninnevomelanocytictumors
AT husameldinelnour differentserotonergicexpressioninnevomelanocytictumors
AT mariannehedblad differentserotonergicexpressioninnevomelanocytictumors
AT efraincazmitia differentserotonergicexpressioninnevomelanocytictumors
AT klasnordlind differentserotonergicexpressioninnevomelanocytictumors
_version_ 1725837386638688256